Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

RIPK1 inhibitors might help prevent alopecia areata.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Dietary changes and supplements mostly did not improve alopecia areata.

Alopecia areata patients have a higher risk of blood clots.

Microneedling mildly regrows hair in androgenetic alopecia but not in other types.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Hypothyroidism may cause certain types of hair loss.

Betamethasone injections are more effective than Clobetasol for treating alopecia areata in children.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Men with alopecia often feel less confident and have lower wellbeing, needing more support.

Topical tofacitinib is effective and safe for treating alopecia areata.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Higher levels of β-carotene and vitamin E may help prevent certain types of hair loss.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Excessive hair loss can be an early sign of celiac disease.

The three-layer microneedle system effectively delivers minoxidil into the skin, showing potential as a safe and efficient treatment for hair loss.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.